RxDoctor Payments Data

Georgiana Hart

Adult Health · Newark, NJNPI 1417140369

Payments from drug & device makers

$2,859in general payments, 2019–2025

Across 194 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$684
  • Vanda Pharmaceuticals Inc.$326
  • Teva Pharmaceuticals USA, Inc.$319
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$299
  • Neurocrine Biosciences, Inc.$287
  • Johnson & Johnson$284
  • plus $659 from 7 others

What the payments were for

  • Food & beverage$2,854100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,859 in reported general payments places this provider in the 85th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$4,966
Medicare patients
31
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl28$40,727
TrintellixVortioxetine Hydrobromide66$32,495
SeroquelQuetiapine Fumarate14$7,424
Aripiprazole164$7,215
Zolpidem Tartrate286$2,379
Clonazepam149$1,887
Bupropion XlBupropion Hcl134$1,777
Zolpidem Tartrate ErZolpidem Tartrate13$1,748
Buspirone Hcl142$1,700
Mirtazapine131$1,595
Naloxone Hcl22$1,316
Alprazolam184$1,225
Lorazepam192$1,217
Haloperidol48$1,149
Lurasidone Hcl34$1,109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$684$40,72728 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$26$32,49566 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →